Ahmed Hamdy M.D., Chief Executive Officer at Vincerx Pharma, Inc. (VINC), bought 24,200 shares at $1.41 ($34K) on 2022-06-23, disclosed to the SEC on 2022-06-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| VINC | BUY | 2021-12-27 | $65K | — | Filing → |
| VINC | BUY | 2021-06-30 | $200K | — | Filing → |
| PCYC | SELL | 2010-10-07 | $123K | — | Filing → |